Glassman Wealth Services Organon & Co. Transaction History

Glassman Wealth Services

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$10.95 - $17.32 $4,588 - $7,257	419 Added 23.33%	2,215 $31,000
Q3 2023 Nov 13, 2023	BUY	$16.59 - $23.77 $2,173 - $3,113	131 Added 7.87%	1,796 $31,000
Q2 2023 Aug 08, 2023	BUY	$19.27 - $24.63 $8,632 - $11,034	448 Added 36.81%	1,665 $34,000
Q1 2023 May 04, 2023	BUY	$21.42 - $32.08 $1,328 - $1,988	62 Added 5.37%	1,217 $28,000
Q4 2022 Feb 06, 2023	BUY	$23.31 - $28.61 $10,489 - $12,874	450 Added 63.83%	1,155 $32,000
Q3 2022 Nov 09, 2022	SELL	$23.4 - $34.25 $8,260 - $12,090	-353 Reduced 33.36%	705 $17,000
Q2 2022 Aug 04, 2022	BUY	$31.66 - $38.9 $33,496 - $41,156	1,058 New	1,058 $36,000
Q1 2022 Apr 14, 2022	SELL	$30.45 - $39.36 $48,141 - $62,228	-1,581 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$28.67 - $37.13 $23,853 - $30,892	832 Added 111.08%	1,581 $48,000
Q3 2021 Nov 10, 2021	BUY	$28.63 - $35.64 $2,977 - $3,706	104 Added 16.12%	749 $25,000
Q2 2021 Aug 04, 2021	BUY	$28.45 - $38.0 $18,350 - $24,510	645 New	645 $20,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.